Abstract:Background: Acute kidney injury (AKI) is a sudden episode of kidney failure which is frequently observed at intensive care units and related to high morbidity/mortality. Although AKI can have many different causes, ischemia–reperfusion (IR) injury is the main cause of AKI. Mechanistically, NADPH oxidases (NOXs) are involved in the pathophysiology contributing to oxidative stress following IR. Previous reports have indicated that knockout of NOX4 may offer protection in cardiac and brain IR, but there is currently less knowledge about how this could be exploited therapeutically and whether this could have significant protection in IR-induced AKI. Aim: To investigate the hypothesis that a novel and specific NOX4 inhibitor (GLX7013114) may have therapeutic potential on kidney and mitochondrial function in a mouse model of IR-induced AKI. Methods: Kidneys of male C57BL/6J mice were clamped for 20 min, and the NOX4 inhibitor (GLX7013114) was administered via osmotic minipump during reperfusion. Following 3 days of reperfusion, kidney function (i.e., glomerular filtration rate, GFR) was calculated from FITC-inulin clearance and mitochondrial function was assessed by high-resolution respirometry. Renal histopathological evaluations (i.e., hematoxylin–eosin) and TUNEL staining were performed for apoptotic evaluation. Results: NOX4 inhibition during reperfusion significantly improved kidney function, as evidenced by a better-maintained GFR (p < 0.05) and lower levels of blood urea nitrogen (p < 0.05) compared to untreated IR animals. Moreover, IR caused significant tubular injuries that were attenuated by simultaneous NOX4 inhibition (p < 0.01). In addition, the level of renal apoptosis was significantly reduced in IR animals with NOX4 inhibition (p < 0.05). These favorable effects of the NOX4 inhibitor were accompanied by enhanced Nrf2 Ser40 phosphorylation and conserved mitochondrial function, as evidenced by the better-preserved activity of all mitochondrial complexes. Conclusion: Specific NOX4 inhibition, at the time of reperfusion, significantly preserves mitochondrial and kidney function. These novel findings may have clinical implications for future treatments aimed at preventing AKI and related adverse events, especially in high-risk hospitalized patients.

ZLN005 protects against ischemia-reperfusion-induced kidney injury by mitigating oxidative stress through the restoration of mitochondrial fatty acid oxidation

ZLN005, a PGC-1α Activator, Protects the Liver against Ischemia–Reperfusion Injury and the Progression of Hepatic Metastases

Postconditioning Ameliorates Mitochondrial DNA Damage and Deletion after Renal Ischemic Injury

Mitoglitazone ameliorates renal ischemia/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET

Lipopolysaccharide-induced Cross-Tolerance Against Renal Ischemia–reperfusion Injury is Mediated by Hypoxia-Inducible Factor-2Α-regulated Nitric Oxide Production

PGC-1α Alleviates Mitochondrial Dysfunction Via TFEB-mediated Autophagy in Cisplatin-Induced Acute Kidney Injury

Mitophagy Mediated by HIF-1α/FUNDC1 Signaling in Tubular Cells Protects Against Renal Ischemia/reperfusion Injury

The PGC-1α Activator ZLN005 Ameliorates Ischemia-Induced Neuronal Injury in Vitro and in Vivo

PGC1α alleviates mitochondrial dysfunction via TFEB‐mediated autophagy in acute kidney injury mice

HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury

Activation of BNIP3-mediated mitophagy protects against renal ischemia–reperfusion injury

Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome

Augmenter of liver regeneration reduces mitochondria-derived ROS and NLRP3 inflammasome activation through PINK1/Parkin-mediated mitophagy in ischemia-reperfusion-induced renal tubular injury

Protective Effects of Liquiritigenin against Cisplatin-Induced Nephrotoxicity via NRF2/SIRT3-Mediated Improvement of Mitochondrial Function

Urolithin A alleviates acute kidney injury induced by renal ischemia reperfusion through the p62‐Keap1‐Nrf2 signaling pathway

Amelioration of Oxidative Mitochondrial DNA Damage and Deletion after Renal Ischemic Injury by the KATP Channel Opener Diazoxide.

Specific NOX4 Inhibition Preserves Mitochondrial Function and Dampens Kidney Dysfunction Following Ischemia–Reperfusion-Induced Kidney Injury

Ischemic Postconditioning Attenuates Acute Kidney Injury Following Intestinal Ischemia-Reperfusion Through Nrf2-regulated Autophagy, Anti-Oxidation, and Anti-Inflammation in Mice.

Ezetimibe Ketone Protects Against Renal Ischemia-Reperfusion Injury and Attenuates Oxidative Stress Via Activation of the Nrf2/HO-1 Signaling Pathway.

Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity.

FOXO1 inhibition prevents renal ischemia–reperfusion injury via cAMP‐response element binding protein/PPAR‐γ coactivator‐1α‐mediated mitochondrial biogenesis